Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Alexander Huang, MD

Member Researcher

Biography

Alexander Huang is an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. His research program focuses on translational cancer immunology research, taking advantage of innovative clinical trials to identify targets for novel immunotherapies in cancer to understand mechanisms of response and resistance, and ultimately to implement precision immuno-oncology in the clinic.

His research involves the integration of immunotherapy trials, flow cytometric and transcriptional approaches, and advanced computational analysis to understand the underlying cellular mechanism of immunotherapies in the human system. Specifically, he has a longstanding interest in the role of PD-1 blockade on CD8 T-cell reinvigoration in human cancer, and he defined the early pharmacodynamic immune response to PD-1 blockade in melanoma.

Dr. Huang holds a BS in science and biomedical engineering from Johns Hopkins University and an MD from Mount Sinai School of Medicine.

Education & Training

  • 2005: John Hopkins University, BS
  • 2008-2009: Doris Duke Research Fellowship, Washington University School of Medicine, St. Louis
  • 2010-2013: Resident in Internal Medicine, Barnes Jewish Hospital, St. Louis
  • 2010: Mount Sinai School of Medicine with Distinction in Research
  • 2013-2017: Fellowship, Hematology/Oncology, Hospital of University of Pennsylvania, Philadelphia

Awards & Honors

  • 2017: Parker Bridge Fellow Awardee
  • 2015: NIH Loan Repayment Grant
  • 2013: Gregory J Gurtner Translational Research Award
  • 2011: Washington University Mentors in Medicine Research Grant
  • 2009: American Association of Allergy, Asthma and Immunology Chrysalis Award
  • 2005: Tau Beta Pi Engineering Honor Society